CLAIM DETAILS
The claim concerns sleep and respiratory care devices manufactured, marketed, and sold by the Defendants, particularly Philips Respironics branded Continuous Positive Airway Pressure (CPAP), Bi-Level Positive Airway Pressure (BIPAP), and Mechanical Ventilators. The devices are manufactured with a Polyester-Based Polyurethane (PE-PUR) sound abatement foam, which degrades over time and under certain conditions into toxic particles which may be inhaled or ingested by the user. The toxic particles may cause cancer, respiratory damage or irritation, inflammation, irritation, nausea/vomiting, hypersensitivity, and/or headache.
Please see the Notice of Civil Claim for more details.
CURRENT STATUS
IMPORTANT UPDATE FOR CLASS MEMBERS: November 10, 2025
See the Notice of Settlement Approval here, which announces the approval of the settlement and the opening of the claim period. Please carefully review.
To submit your claim, please visit https://cpapsettlement.kpmg.ca/#claims.
